Lineage Cell Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of LCTX for the last quarter is 2.09 M USD, and it's 67.58% higher compared to the previous quarter. The net income of Q4 23 is -4.78 M USD.